Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest

Related Posts

Altech Batteries LimitedAcquisition of Additional Investments CERENERGY and...

February 28, 2025

Licence Application Granted for Ulytau Uranium Project

September 4, 2024

Eclipse Metals and Boss Energy Sign Binding Option...

March 10, 2025

Awalé Provides Progress Update for Odienné Project

February 27, 2025

Nuclear Fuels Closes Private Placement

August 14, 2024

Accelerated Non-Renounceable Entitlement Offer Results

December 3, 2024

Mkango’s Q3 Results Highlight Progress at US, UK...

November 30, 2024

Building A Growing West Australian Gold Producer

August 1, 2024

Energy Fuels: Uranium Sector Strong, Now Ramping Up...

October 4, 2024

​Tech 5: Alphabet, Meta and Microsoft Close at...

January 29, 2024